Health workers dressed in protective gear begin their shift at an Ebola treatment center in Beni, Congo DRC, Tuesday, July 16, 2019. (AP Photo/Jerome Delay, File)
Copyright © africanews
By Agencies
Last updated:
12 minutes ago
WHO experts say early evidence, including animal studies, suggests Ervebo could offer some protection—and the new trial will seek to establish whether that protection extends to humans.
Health workers dressed in protective gear begin their shift at an Ebola treatment center in Beni, Congo DRC, Tuesday, July 16, 2019. (AP Photo/Jerome Delay, File)
Copyright © africanews
By Agencies
Last updated:
12 minutes ago

The International Coordinating Group on Vaccine Provision, which includes the WHO and other partners, said the doses will be…

WHO says vaccines for Ebola virus disease being allocated to DRC amid largest outbreak that has killed nearly 2,500.

WHO said in a statement that while it’s not known whether Ervebo may protect against the Bundibugyo virus, “early laboratory and…

The doses of the Ervebo vaccine, which has proved safe and effective against the Zaire strain of Ebola virus, are being released…

The World Health Organization says Congo will receive 70,000 doses of the Ervebo vaccine

The Democratic Republic of the Congo (DRC) will receive 70,000 doses of the Ervebo vaccine from the UN’s international vaccine…

Congo to receive 70,000 doses of Ervebo Ebola vaccine, which was effective in past outbreaks